To increase the potential for the wide-scale application of our direct agglutination test for visceral leishmaniasis, modifications in the components and procedures were introduced. Supplementation with 0.056 M citrate of the suspension medium stabilized the antigen for 9 weeks at 3rC. To circumvent the need for cooling systems in the field, 0.2% (wt/vol) gelatin was added to the serum diluent instead of fetal bovine serum, with reliable results. Specificity and sensitivity were improved by the incorporation of 0.1 M 2-mercaptoethanol in samples with borderline titers. The test could be performed on samples of whole blood; thus the difficulties of preparation and storage of serum, plasma, or filter paper blood are avoided. For mass screening programs, a single serum dilution of 1:6,400 could be employed, contributing to a further reduction in test expenses. Sera from different geographical areas showed equal reactivities in this direct agglutination test despite the nonhomologous Leishmania donovani antigens used.
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A limited number of the available serological methods for provisional diagnosis of visceral leishmaniasis (VL) and for epidemiological studies of this disease are suitable for field application (7, 8, 11) . Among the factors limiting the use of these methods are the instability of reagents and the need for sophisticated equipment and specialized skills.
A recently developed direct agglutination test (DAT) showed promise in fulfilling the requirements of a field test (4, 5) , but further improvement and simplification were considered necessary for on-site field work. We report on a number of modifications in this DAT.
MATERIALS AND METHODS
Antigen production and test procedures. The detailed performance of the DAT has been previously reported (5) . Briefly, promastigotes of Leishmania donovani were maintained in modified Dwyer medium (3), with beef extract substitution. Defibrinated rabbit blood, yeast extract (5.0 g/ liter), and tryptose (0.1 g/liter; Difco Laboratories, Detroit, Mich.) were added to the basic medium. Mass production of the parasite was obtained by inoculating 1 liter of RPMI 1640 to which HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) and fetal bovine serum (FBS) were added with 20 ml of rich promastigote maintenance culture. After (i) Extension of antigen shelf life. The procedure for antigen production was the same up to the step of formaldehyde fixation before staining. After centrifugation, the parasites were suspended and washed two times with cold (4°C) saline (0.15 M NaCl) adjusted to pH 7.4 with sodium citrate (0.056 M). The parasites were then stained with Coomassie brilliant blue in the same citrate-saline solution. After being washed three times and suspended (at 6.5 x 107 to 7.5 x 107/ml) in citrate-saline plus formaldehyde (0.43% [wt/vol]), the antigen suspension was filtered. The antigen preparation was tested before storage and at several intervals after storage at 4, 21, 37, and 45°C with positive and negative reference sera.
(ii) Substitution of FBS by gelatin in serum diluent. Instead of the above-described serum diluent of normal saline with 1% FBS, a modified diluent was used consisting of an aqueous solution of sodium citrate (0.056 M) and sodium chloride (0.15 M) to which 0.2% gelatin (Difco) was added. The mixture was heated at 56°C for 10 min to dissolve the gelatin and then left to cool at room temperature. Sera diluted with this solution were used in the standard test procedure. When citrate had already been added to the antigen, it could be eliminated from the gelatin diluent without affecting the observed titers.
(iii) Addition of 2-ME. As reported for the test for Chagas' disease (6, 12, 15), 2-mercaptoethanol (2-ME) was added to sera showing borderline titers (1:1,600 to 1:6,400); 0.1 M 2-ME was added to the gelatin diluent, and the test was further performed as described above.
(iv) Use of whole blood and filter paper blood. (5). To assess the reliability of using a single sample dilution, 109 sera diluted at 1:3,200 or 1:6,400 in gelatin were tested for positive or negative readings.
The sera tested were obtained from patients with VL (n = 10), African trypanosomiasis (n = 10), and autoimmune disorders (n = 10) and from healthy Kenyans as controls (n = 79).
Human Sera and blood collected on filter papers were obtained from 91 persons. In the field, the dried filter papers were kept at 4°C for 2 weeks; on their arrival in Amsterdam, the filter papers were frozen at -20°C. Filter papers were eluted to give a dilution of 1:50.
From Brazil, 251 sera from healthy Brazilian donors and patients with infections other than VL were tested. For India, 11 sera of attendants or family members of patients with VL were included. RESULTS Stabilization of antigen. The titers obtained with the four aliquots of antigen during the periods studied fluctuated within an acceptable range (Fig. 1) . Longer storage resulted in the formation of clumps and the fading of antigen color. Even at temperatures as high as 37 to 45°C, the antigen suspension to which citrate had been added showed consistent reactivity for at least 3 weeks after preparation.
Serum diluent. No significant difference between readings was noticed with FBS or gelatin as protein source in the serum diluent (standard Pearson correlation coefficient, 0.9857; P < 10-6) (Fig. 2) .
2-ME addition to sera. Except for one sample from a treated patient with VL, all the other samples had significantly higher titers after 2-ME treatment (Table 1 ). In addition, nonspecific agglutination reactions were clearly reduced in sera of patients of all other conditions tested except African trypanosomiasis.
Whole blood and filter paper blood. Similar results were obtained with whole mouse blood, filter paper-collected blood, and the corresponding plasma samples. Titers of '1: 1,600 and .1:12,800 were obtained for the nonimmunized control group (n = 12) and the L. donovani-immunized group (n = 16), respectively. Dilution of whole mouse blood at 1: 1,600 presented no problems in the reading of DAT results. This improvement was also observed with human whole blood supplemented with sera from patients with kala azar (results not shown).
Results with filter paper-collected blood and with serum samples collected from people in the field were significantly correlated (standard Pearson correlation coefficient, 0.987; P < 10-6). Among 91 samples collected by either procedure, 3 sera and 3 filter paper eluates revealed titers of .1:12,800.
These samples were later disclosed to have been collected from patients with VL. In general, filter paper eluates had slightly lower titers than those of the corresponding serum samples, but patients with VL and noninfected persons (titers of <1:1,600) were clearly distinguished (Table 2) .
Single dilution testing. Testing of 109 human serum samples at single dilutions of 1:3,200 or 1:6,400 by DAT (Table 3) revealed 15 and 9 seropositive samples at the former and latter dilutions, respectively. As expected, the sera of all 10 patients with kala azar were positive at a dilution of 1:3,200; 8 samples were also positive at a dilution of 1:6,400, but samples from 2 treated cases were negative at this dilution.
Sera from different areas where VL is endemic. Active and treated (up to 6 months) VL cases from Kenya, Brazil, and India had DAT titers indicative of the disease (.1:12,800).
Except for 18 samples, all other control sera (528 samples) from Kenya were clearly seronegative (titers of <1:1,600; Table 4 ). The addition of 2-ME resulted in the improvement of specificity (98.8%) and sensitivity (100%). Similar improvement in the specificities of previously developed direct agglutination assays for Chagas' disease has been reported (6, 12, 15) . It is not yet clear how 2-ME removes nonspecific agglutination reactions while augmenting or at least maintaining specific ones. Experiments are in progress to investigate this effect of 2-ME. 2-ME can easily be incorporated in sera for the field application of the DAT.
Whole blood has not previously been used in the immunodiagnostic methods for VL. The results with mouse whole blood samples were similar to those with corresponding plasma samples. At the dilution chosen (1:1,600), erythrocyte sedimentation was so slight that it caused no confusion in the reading of the test. When sera from patients with kala azar were added to human whole blood, a dilution of 1:1,600 was also sufficient to avoid the problem of erythrocyte If only positive and negative readings are required, the DAT can be performed on the basis of a single dilution. This method will enable the screening of large populations in a reasonable period. A dilution of 1:6,400 appears to be reliable for the detection of active kala azar cases in a population including patients with African trypanosomiasis. The cutoff point has to be established in every endemic area; it is likely to be around 1:6,400.
Irrespective of their geographic origin, active VL sera from Kenya, Brazil, or India showed titers indicative of the disease (.1:3,200). We have worked with a L. donovani stock; it is not clear which subspecies this is, but it is clear that this antigen can be used to test sera from patients which were infected with different subspecies of L. donovani. The introduction of the above-described DAT into those areas where VL is endemic seems warranted. Further studies involving primary isolates of L. donovani from different areas where VL is endemic are in progress. Although reliable diagnostic information can be obtained within 4 to 5 
